Hrt Financial LP Kiniksa Pharmaceuticals, Ltd. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$14.37 - $19.07 $1.08 Million - $1.43 Million	74,866 New	74,866 $1.31 Million
Q4 2022 Feb 10, 2023	BUY	$11.42 - $17.05 $453,956 - $677,754	39,751 New	39,751 $595,000
Q2 2022 Aug 12, 2022	SELL	$7.6 - $11.41 $447,442 - $671,752	-58,874 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.3 - $12.37 $547,528 - $728,271	58,874 New	58,874 $585,000
Q4 2021 Feb 14, 2022	SELL	$10.39 - $15.15 $196,048 - $285,865	-18,869 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.39 - $16.23 $214,917 - $306,243	18,869 New	18,869 $214,000
Q1 2020 May 15, 2020	SELL	$11.0 - $19.76 $355,300 - $638,248	-32,300 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.24 - $12.96 $169,252 - $418,608	32,300 New	32,300 $357,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.